10 News & Press Releases found
Atmo Biosciences News
-
Atmo Biosciences secures $9.6 million in oversubscribed capital raise
Atmo Biosciences has closed a successful, oversubscribed A$9.6m capital raise. The raise was led by two new, cornerstone investors – Sydney-based investment firm Alium Capital Management and Japanese multinational company Otsuka ...
-
Atmo featured on Medical Director’s Healthtech Showcase
Atmo Biosciences CEO Mal Hebblewhite was invited to present at Medical Director’s Healthtech Showcase. In the video below, Mal gives an overview of Atmo Biosciences then talks to showcase host Dominique Powis about Atmo’s journey so ...
-
Study results presented at AGW show Atmo Gas Capsule can be used to assess regional gastrointestinal transit in healthy adults
A Monash University comparative study has found Atmo Biosciences’ novel ingestible gas-sensing capsule to be similar to a validated wireless motility capsule (WMC) when assessing regional gastrointestinal transit time in healthy adults. ...
-
Atmo Biosciences awarded Victorian Government Technology Adoption and Innovation Program grant to support software development
Atmo Biosciences has been awarded a Victorian Government Technology Adoption and Innovation Program (TAIP) grant to support the software development for the Atmo Gas Capsule. The TAIP supports Victorian small to medium size enterprises ...
-
Atmo Biosciences awarded Australian Government grant to automate and scale-up manufacturing of ingestible gas-sensing capsule
Atmo Biosciences has been awarded an Australian Government Manufacturing Modernisation Fund (MMF) grant to support manufacturing automation and scale-up for the Atmo Gas-Sensing Capsule. The Round 2 MMF grants, part of the Government’s ...
-
Atmo Biosciences’ ingestible gas-sensing capsule to be used in Swedish IBS trial led by Professor Magnus Simrén
Atmo Biosciences’ world-first ingestible gas-sensing capsule is being used in a clinical trial led by renowned gastroenterologist Professor Magnus Simrén currently underway at Sweden’s University of Gothenburg. The trial named ...
-
Atmo Biosciences wins Early Stage Investment Forum at AusBiotech
Atmo Biosciences beat 10 other contenders to win the Early Stage Investment Forum (ESIF) at AusBiotech 2019, held at the Melbourne Convention Centre last week. The ESIF is a key element of the annual AusBiotech conference featuring short pitches ...
-
Atmo Biosciences signs deal with RMIT University to commercialize ingestible gas-sensing capsule for gut health
Atmo Biosciences has signed a licensing deal with RMIT University securing the exclusive worldwide rights to commercialize a ground-breaking ingestible gas-sensing capsule. The Atmo Gas Capsule is set to revolutionize how doctors diagnose and treat ...
-
Human trials underway for first generation Atmo Gas Capsule
Two human trials of Atmo Biosciences’ ingestible gas-sensing capsule have begun. The first trial is being conducted at Monash University and the Alfred Hospital in Melbourne, Australia, in collaboration with the research team led by Professor ...
-
Atmo exhibits at Australian Gastroenterology Week
Atmo Biosciences exhibited at Australian Gastroenterology Week Conference in Adelaide thanks to the generous support of C.R. Kennedy. CEO Mal Hebblewhite reported plenty of interest from gastroenterologists regarding the two clinical trials Atmo ...